HUN · Huntsman Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.42B | - | $1.46B | $1.46B | $1.41B | - | $1.54B | $1.57B | $1.47B | - |
| Cost of Revenue | $1.24B | - | $1.26B | $1.28B | $1.21B | - | $1.31B | $1.33B | $1.27B | - |
| Gross Profit | $183.00M | - | $204.00M | $182.00M | $201.00M | - | $234.00M | $243.00M | $201.00M | - |
| R&D | $29.00M | - | $29.00M | $33.00M | $32.00M | - | $27.00M | $33.00M | $31.00M | - |
| SG&A | $163.00M | - | $163.00M | $160.00M | $166.00M | - | $153.00M | $176.00M | $176.00M | - |
| Total Operating Expenses | $199.00M | - | $198.00M | $302.00M | $159.00M | - | $192.00M | $209.00M | $239.00M | - |
| D&A | $73.00M | - | $73.00M | $72.00M | $69.00M | - | $70.00M | $75.00M | $69.00M | - |
| Operating Income | ($16.00M) | - | $6.00M | ($120.00M) | $42.00M | - | $42.00M | $34.00M | ($38.00M) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $11.00M | - | $3.00M | $7.00M | $15.00M | - | $39.00M | $13.00M | ($20.00M) | - |
| Net Income | ($53.00M) | - | ($25.00M) | ($158.00M) | ($5.00M) | - | ($33.00M) | $22.00M | ($37.00M) | - |
| EPS - Basic | ($0.31) | - | ($0.14) | ($0.92) | ($0.03) | - | ($0.19) | $0.13 | ($0.22) | - |
| EPS - Diluted | ($0.31) | - | ($0.14) | ($0.92) | ($0.03) | - | ($0.19) | $0.13 | ($0.22) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $369.00M | $429.00M | $468.00M | $399.00M | $334.00M | $340.00M | $330.00M | $335.00M | $552.00M | $540.00M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | $885.00M | $818.00M | $836.00M | $896.00M | $1.03B | $917.00M | $1.00B | $923.00M | $896.00M | $867.00M |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $2.18B | $2.06B | $2.18B | $2.21B | $2.29B | $2.13B | $2.29B | $2.25B | $2.44B | $2.31B |
| Total Assets | $7.13B | $7.01B | $7.08B | $7.15B | $7.23B | $7.11B | $7.33B | $7.32B | $7.57B | $7.25B |
| Current Liabilities | $1.72B | $1.59B | $1.60B | $1.54B | $1.54B | $1.56B | $1.56B | $1.73B | $1.58B | $1.17B |
| Long-term Debt | $1.68B | $1.66B | $1.63B | $1.66B | $1.67B | $1.51B | $1.51B | $1.34B | $1.66B | $1.68B |
| Total Liabilities | $4.23B | $4.06B | $4.08B | $4.09B | $4.06B | $3.95B | $3.99B | $3.98B | $4.18B | $3.77B |
| Stockholders' Equity | $2.68B | $2.75B | $2.77B | $2.83B | $2.95B | $2.96B | $3.11B | $3.11B | $3.15B | $3.25B |
| Retained Earnings | $1.74B | $1.81B | $1.92B | $1.99B | $2.19B | $2.25B | $2.43B | $2.51B | $2.53B | $2.62B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($53.00M) | - | - | - | ($74.00M) | - | - | - | ($65.00M) | - |
| Investing Cash Flow | ($37.00M) | - | - | - | $6.00M | - | - | - | ($30.00M) | - |
| Financing Cash Flow | $30.00M | - | - | - | $60.00M | - | - | - | $108.00M | - |
| CapEx | $38.00M | - | - | - | $36.00M | - | - | - | $42.00M | - |
| Free Cash Flow | ($91.00M) | - | - | - | ($110.00M) | - | - | - | ($107.00M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 12.9% | - | 14.0% | 12.5% | 14.3% | - | 15.2% | 15.4% | 13.7% | - |
| Operating margin | -1.1% | - | 0.4% | -8.2% | 3.0% | - | 2.7% | 2.2% | -2.6% | - |
| EBITDA margin | 4.0% | - | 5.4% | -3.3% | 7.9% | - | 7.3% | 6.9% | 2.1% | - |
| Net margin | -3.7% | - | -1.7% | -10.8% | -0.4% | - | -2.1% | 1.4% | -2.5% | - |
| Free cash flow margin | -6.4% | - | - | - | -7.8% | - | - | - | -7.3% | - |
| FCF / Net income | 1.72 | - | - | - | 22.00 | - | - | - | 2.89 | - |
| R&D / Revenue | 2.0% | - | 2.0% | 2.3% | 2.3% | - | 1.8% | 2.1% | 2.1% | - |
| SG&A / Revenue | 11.5% | - | 11.2% | 11.0% | 11.8% | - | 9.9% | 11.2% | 12.0% | - |
| Effective tax rate | - | - | - | - | 150.0% | - | 650.0% | 37.1% | - | - |
| Return on assets | -0.7% | - | -0.4% | -2.2% | -0.1% | - | -0.4% | 0.3% | -0.5% | - |
| Return on equity | -2.0% | - | -0.9% | -5.6% | -0.2% | - | -1.1% | 0.7% | -1.2% | - |
| Return on invested capital | -0.3% | - | 0.1% | -2.1% | 0.5% | - | 0.5% | 0.5% | -0.6% | - |
| Liquidity | ||||||||||
| Current ratio | 1.27 | 1.30 | 1.36 | 1.43 | 1.48 | 1.36 | 1.47 | 1.30 | 1.55 | 1.97 |
| Quick ratio | 0.75 | 0.78 | 0.84 | 0.85 | 0.82 | 0.77 | 0.83 | 0.77 | 0.98 | 1.23 |
| Cash ratio | 0.21 | 0.27 | 0.29 | 0.26 | 0.22 | 0.22 | 0.21 | 0.19 | 0.35 | 0.46 |
| Leverage | ||||||||||
| Debt / Equity | 0.63 | 0.60 | 0.59 | 0.59 | 0.57 | 0.51 | 0.49 | 0.43 | 0.53 | 0.52 |
| Debt / Assets | 0.24 | 0.24 | 0.23 | 0.23 | 0.23 | 0.21 | 0.21 | 0.18 | 0.22 | 0.23 |
| Debt / EBITDA | 29.47 | - | 20.63 | - | 15.05 | - | 13.51 | 12.33 | 53.55 | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 2.66 | 2.55 | 2.56 | 2.53 | 2.45 | 2.40 | 2.36 | 2.35 | 2.40 | 2.23 |
| Liabilities / Assets | 0.59 | 0.58 | 0.58 | 0.57 | 0.56 | 0.56 | 0.54 | 0.54 | 0.55 | 0.52 |
| Efficiency | ||||||||||
| Asset turnover | 0.20 | - | 0.21 | 0.20 | 0.19 | - | 0.21 | 0.22 | 0.19 | - |
| Inventory turnover | 1.40 | - | 1.50 | 1.42 | 1.17 | - | 1.30 | 1.44 | 1.42 | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 261d | - | 243d | 256d | 311d | - | 281d | 253d | 258d | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | 175.2x | - | - |
| P / B | 0.9x | - | 0.6x | 0.6x | 0.9x | - | 1.3x | 1.3x | 1.4x | - |
| P / S | 1.6x | - | 1.1x | 1.2x | 1.9x | - | 2.7x | 2.5x | 3.0x | - |
| EV / EBITDA | 63.4x | - | 34.3x | - | 36.6x | - | 47.7x | 45.4x | 180.0x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 0.7% | - | -5.2% | -7.4% | -4.1% | - | 2.3% | -1.4% | -8.5% | - |
| Revenue CAGR (3y) | -4.0% | - | -10.1% | -14.9% | -16.1% | - | -12.3% | -8.0% | -7.2% | - |
| Revenue CAGR (5y) | -5.0% | - | -0.7% | 3.2% | -2.4% | - | -1.8% | -6.4% | -6.3% | - |
| Gross profit growth (YoY) | -9.0% | - | -12.8% | -25.1% | 0.0% | - | 1.3% | -4.3% | -25.3% | - |
| Operating income growth (YoY) | - | - | -85.7% | - | - | - | 55.6% | -32.0% | - | - |
| Net income growth (YoY) | -960.0% | - | 24.2% | - | 86.5% | - | - | 15.8% | - | - |
| EPS growth (YoY) | -933.3% | - | 26.3% | - | 86.4% | - | - | 18.2% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | -42.9% | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | -22.7% | - | - |
| FCF growth (YoY) | 17.3% | - | - | - | -2.8% | - | - | - | 46.5% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -9.1% | -7.1% | -11.1% | -9.2% | -6.4% | -9.0% | -9.2% | -13.9% | -16.2% | -10.3% |
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing Huntsman CORP against the 5 most active filers in the same SIC group.
Dividends
$0.68/share trailing 12 months · -32.4% YoY
| Ex-date | Per share |
|---|---|
| Mar 13, 2026 | $0.0880 |
| Dec 15, 2025 | $0.0880 |
| Sep 15, 2025 | $0.2500 |
| Jun 13, 2025 | $0.2500 |
| Mar 14, 2025 | $0.2500 |
| Dec 13, 2024 | $0.2500 |
| Sep 13, 2024 | $0.2500 |
| Jun 14, 2024 | $0.2500 |
| Mar 14, 2024 | $0.2500 |
| Dec 14, 2023 | $0.2380 |
| Sep 14, 2023 | $0.2380 |
| Jun 14, 2023 | $0.2380 |
| Mar 14, 2023 | $0.2380 |
| Dec 14, 2022 | $0.2130 |
| Sep 14, 2022 | $0.2130 |
| Jun 14, 2022 | $0.2130 |
| Mar 14, 2022 | $0.2130 |
| Dec 14, 2021 | $0.1880 |
| Sep 14, 2021 | $0.1880 |
| Jun 14, 2021 | $0.1880 |
| Mar 12, 2021 | $0.1630 |
| Dec 14, 2020 | $0.1630 |
| Sep 14, 2020 | $0.1630 |
| Jun 12, 2020 | $0.1630 |